Last quarter (Q4 2022), Actinogen Medical Limited's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Actinogen Medical Limited's net income was $―. See Actinogen Medical Limited’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Total Revenue	$ ―	$ ―	$ ―	$ ―	$ 80.82K	$ ―
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ ―	$ 80.82K	$ ―
Operating Expense	$ ―	$ 13.17M	$ 5.90M	$ 8.91M	$ 14.47M	$ 9.56M
Operating Income	$ ―	$ -13.17M	$ -5.90M	$ -8.91M	$ -14.47M	$ -9.56M
Net Non Operating Interest Income Expense	$ ―	$ 22.59K	$ 4.77K	$ 65.17K	$ 196.56K	$ 27.26K
Other Income Expense	$ ―	$ 3.65M	$ 1.98M	$ 3.52M	$ 4.39M	$ 3.30M
Pretax Income	$ ―	$ -9.50M	$ -3.92M	$ -5.33M	$ -9.89M	$ -6.23M
Tax Provision	$ ―	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ ―	$ -9.50M	$ -3.92M	$ -5.33M	$ -9.89M	$ -6.23M
Basic EPS	$ ―	$ >-0.01	$ >-0.01	$ >-0.01	$ >-0.01	$ >-0.01
Diluted EPS	$ ―	$ >-0.01	$ >-0.01	$ >-0.01	$ >-0.01	$ >-0.01
Basic Average Shares	$ ―	$ 1.72B	$ 1.41B	$ 1.14B	$ 1.12B	$ 705.09M
Diluted Average Shares	$ ―	$ 1.72B	$ 1.41B	$ 1.14B	$ 1.12B	$ 705.09M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income From Continuing And Discontinued Operation	$ ―	$ -9.50M	$ -3.92M	$ -5.33M	$ -9.89M	$ -6.23M
Normalized Income	$ ―	$ -9.50M	$ -3.92M	$ -5.33M	$ -9.41M	$ -6.23M
Interest Expense	$ ―	$ 18.48K	$ 22.32K	$ 28.88K	$ 7.99K	$ 11.46K
EBIT	$ ―	$ -9.48M	$ -3.89M	$ -5.30M	$ -9.88M	$ -6.22M
EBITDA	$ ―	$ -9.08M	$ -3.51M	$ -4.89M	$ -9.53M	$ -5.86M

Currency in USD

Actinogen Medical Limited Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing